We report herein the application of the phosphoramidate ProTide technology to improve the metabolism of the DNA methytransferase inhibitor, zebularine (Z). Zebularine is a riboside that must undergo a complex metabolic transformation before reaching the critical 2'-deoxyzebularine 5'-triphosphate (dZTP). Because 2'-deoxyzebularine (dZ) is not phosphorylated and therefore inactive, the ProTide strategy was employed to bypass the lack of phosphorylation of dZ and the inefficient reduction of zebularine 5'-diphosphate by ribonucleotide-diphosphate reductase required for zebularine. Several compounds were identified as more potent inhibitors of DNA methylation and stronger inducers of p16 tumor suppressor gene than zebularine. However, their activity was dependent on the administration of thymidine to overcome the potent inhibition of thymidylate synthase (TS) and deoxycytidine monophosphate (dCMP) deaminase by dZMP, which deprives cells of essential levels of thymidine. Intriguingly, the activity of the ProTides was cell line-dependent, and activation of p16 was manifest only in Cf-Pac-1 pancreatic ductal adenocarcinoma cells.
We report herein the application of the phosphoramidate ProTide technology to improve the metabolism of the DNA methytransferase inhibitor, n class="Chemical">zebularine (Z). Zebularine is a riboside that must undergo a complex metabolic transformation before reaching the critical 2'-deoxyzebularine 5'-triphosphate (dZTP). Because 2'-deoxyzebularine (dZ) is not phosphorylated and therefore inactive, the ProTide strategy was employed to bypass the lack of phosphorylation of dZ and the inefficient reduction of zebularine 5'-diphosphate by ribonucleotide-diphosphate reductase required for zebularine. Several compounds were identified as more potent inhibitors of DNA methylation and stronger inducers of p16tumor suppressor gene than zebularine. However, their activity was dependent on the administration of thymidine to overcome the potent inhibition of thymidylate synthase (TS) and deoxycytidine monophosphate (dCMP) deaminase by dZMP, which deprives cells of essential levels of thymidine. Intriguingly, the activity of the ProTides was cell line-dependent, and activation of p16 was manifest only in Cf-Pac-1pancreatic ductal adenocarcinoma cells.
Authors: Jonathan C Cheng; Cindy B Matsen; Felicidad A Gonzales; Wei Ye; Sheldon Greer; Victor E Marquez; Peter A Jones; Eric U Selker Journal: J Natl Cancer Inst Date: 2003-03-05 Impact factor: 13.506
Authors: Jonathan C Cheng; Christine B Yoo; Daniel J Weisenberger; Jody Chuang; Chandra Wozniak; Gangning Liang; Victor E Marquez; Sheldon Greer; Torben F Orntoft; Thomas Thykjaer; Peter A Jones Journal: Cancer Cell Date: 2004-08 Impact factor: 31.743
Authors: M Gonzalez-Zulueta; C M Bender; A S Yang; T Nguyen; R W Beart; J M Van Tornout; P A Jones Journal: Cancer Res Date: 1995-10-15 Impact factor: 12.701
Authors: Jonathan C Cheng; Daniel J Weisenberger; Felicidad A Gonzales; Gangning Liang; Guo-Liang Xu; Ye-Guang Hu; Victor E Marquez; Peter A Jones Journal: Mol Cell Biol Date: 2004-02 Impact factor: 4.272
Authors: Sara D'Souza; Justin E Miller; Jenny Ahn; Raechel Subandi; Daniel Lozano; James Ramirez; Marisa Goff; Christina Davidian; Jeffrey H Miller Journal: Antimicrob Agents Chemother Date: 2019-01-29 Impact factor: 5.191
Authors: Stephen P Zano; Caroline Pate; Matthew Frank; Charles O Rock; Suzanne Jackowski Journal: Mol Genet Metab Date: 2015-10-29 Impact factor: 4.797